Chief Medical Officer

Position Title: Chief Medical Officer, Lupus Therapeutics

Reports to: President & CEO, Lupus Research Alliance

Location:

Remote (US-Based), w/ occasional travel

Salary: $300,000 - $350,000 (Starting salary may vary based on candidate qualifications, location, and other factors).

The Lupus Research Alliance (LRA) is the largest non-governmental, non-profit funder of lupus research worldwide. The organization aims to transform treatment by funding the most innovative lupus research, fostering diverse scientific talent, and driving discovery toward better diagnostics, improved treatments and ultimately a cure for lupus. LRA’s Board of Directors funds all administrative and fundraising costs, 100% of all donations goes to support lupus research programs.

The organization was born from the merger of three organizations: the Lupus Research Institute (LRI) and the S.L.E. Lupus Foundation with the Alliance for Lupus Research (ALR), which was founded by Robert Wood “Woody” Johnson IV — a member of the Johnson & Johnson family and owner of the New York Jets. The Lupus Research Alliance is now the world’s leading catalyst driving innovative research that can transform the lives of all affected by the disease — patients, their loved ones and the entire lupus community.

The Chief Medical Officer (CMO), of LRA’s clinical affiliate, Lupus Therapeutics (LT) is responsible for providing drug development, clinical research, and clinical care leadership to the Lupus Research Alliance in collaboration with the Lupus Clinical Investigators Network (LuCIN).

As a member of LRA’s executive team (ET), the CMO acts as a strategic thought leader as well as a partner to the Chief Executive Officer, Chief Scientific Officer and LT Board of Directors. The CMO establishes the strategic and tactical direction of LT’s clinical trial portfolio and patient engagement & education activities, ensuring that LT programs and initiatives are impactful, scalable, sustainable, and measurable.

The CMO will represent the organization internally and externally as a clinical care and drug development expert in lupus.

The CMO will demonstrate and uphold LRA’s values of science-focused, impact-driven, collaborative, equity-focused, patient-centered, innovative, and accountable.

LT consists of twelve full-time employees. The LRA national office provides all other support. The LT team is fully remote with planned in-person meetings primarily on the east coast.

• Provides leadership on all LT programmatic initiatives related to clinical research and clinical care of people living with lupus in alignment with the strategic vision and mission of the LRA.
• Provides direct oversight and management of LT business operations and services to support clinical development programs and advisory activities leveraging the expertise of LuCIN to advance the development of novel lupus therapies.
• Generates new business and collaboration opportunities and develops relationships with biopharmaceutical partners and academia to grow a robust business pipeline to advance organizational interests.
• Remains current on lupus clinical care and clinical research advances and serves as an expert resource for staff, Board of Directors, external agencies, companies and individuals; and provides clinical perspective to inform patient education, communications, research funding, fundraising, advocacy and outreach efforts.
• Serves as a thought leader on clinical research and patient care issues and represents the LRA/LT in national media, at national and international conferences and meetings.
• Communicates outcomes, progress, and impact of LT’s clinical trial portfolio and patient engagement & education programs to a wide array of constituents.
• Collaborates with the Advancement team in the development of funding proposals from the biopharmaceutical industry and other third-party sources for LT-centric programs.
• Collaborates closely with the leads of Research, Clinical Operations, Patient Engagement & Education, Advancement and Lupus Ventures to ensure alignment of all LRA programs across the research continuum
• Serves as a contributor on…